Medical Devices Today

Deal of the Week: Gen-Probe offers to buy Innogenetics for $334mm

Gen-Probe (nucleic acid diagnostics) has launched a tender offer to buy all the outstanding shares, warrants, and convertible bonds of public molecular diagnostics company Innogenetics NV for $334mm (€215mm) in cash. Gen-Probe will pay $9.49 (a 7% premium) for each Innogenetics common share, or $293mm.

Active Lead Launch

Full brief reprinted from "The Gray Sheet" - June 23, 2008

Medtronic will launch what it describes as the "first-ever active fixation left-heart lead" for cardiac resynchronization therapy later this summer following a recent PMA approval. The Attain StarFix OTW 5-French lead relies on pliable polyurethane lobes that can be relaxed by a physician following lead placement to reposition the device in a manner that significantly lessens the risk of dislodgement, the firm says. The lead can be used with any Medtronic CRT defibrillator.

Start your 30-day, risk-free trial of "The Gray Sheet" today!

How To Maximize Your Reimbursement Value Through Pharmacoeconomic And Outcomes Research

F-D-C Reports, Windhover Information and Boston Healthcare Associates proudly present:

How To Maximize Your Reimbursement Value Through Pharmacoeconomic And Outcomes Research

Adapting to the Changing Dossier Environment: Creating Pharmacoeconomic and Health Outcomes Data That Will Impact Coverage and Formulary Decisions

WEBINAR: Thursday, June 26, 2008 - 12:00 pm ET / 9 am PT / 90 minutes - This Webinar is now over. To order a CD of the event please contact Heej Ko at Tel: +1 (203) 838-4401 x 133.

FEATURING:

• Gina Ford, Executive Director - Boston Healthcare
• Phil Cyr, Director - Boston Healthcare
• Click here for speaker bios

LipoSonix: Addition by Subtraction

Back by popular demand: In light of the recent LipoSonix acquisition by Medicis, we dug this article out of the archives. Article preview from IN VIVO - October 2005

Raising money in medical devices is rarely easy; in fact, just getting past the front door can sometimes be a challenge. But not for ultrasound company, LipoSonix. The reason: LipoSonix is working on an energy-based alternative to liposuction, whose concept is easy to understand and its appeal immediate to both physicians and patients.

Is Spine Surgery Under Assault?

Article preview from IN VIVO - May 2008

Find out why a recent article published in JAMA has spine surgeons crying foul?

Acrobot Pursues Orthopedic Partners In Multiple Markets

Article preview reprinted from "The Gray Sheet" - June 16, 2008

Acrobot is seeking a partner to help market its line of "intelligent surgical tools" in the U.S. orthopedic implant surgery market beginning in 2009.

FDA Nixes Baseline Reports

Full brief reprinted from "The Gray Sheet" - June 16, 2008

Find out what form the FDA's June 13, 2008 final rule has eliminated.

Indian Semiconductor Makers See Medical Device Opportunities

Full summary reprinted from PharmAsia News - June 19, 2008

Find out why Indian semiconductor manufacturers are eyeing the medical device sector.

Start-up ENT device maker Acclarent files to go public

Deal summary reprinted from Strategic Transactions - June 2008

Find out more about Acclarent's (sinus surgical devices) recent filing to to go public.

The Fischell Family's Secret of Success

Article preview reprinted from Start-Up - April 2008

START-UP interviews four of the most productive medical device inventors and company creators in the industry, and they're all members of the Fischell family.